Special Collections

The Discussion Room

Vivian P. Bykerk, MD, an attending rheumatologist at the Hospital for Special Surgery (HSS), New York, and Susan M. Goodman, MD, an attending physician at HSS, discuss Janus kinase (JAK)-1 inhibitors in psoriatic arthritis (PsA), how to best approach risk-benefit treatment discussions for patients who may benefit from JAK-1 therapy, and the promise of precision medicine in treating PsA.